Cargando…

Dynamic Regulation of Tgf-B Signaling by Tif1γ: A Computational Approach

TIF1γ (Transcriptional Intermediary Factor 1 γ) has been implicated in Smad-dependent signaling by Transforming Growth Factor beta (TGF-β). Paradoxically, TIF1γ functions both as a transcriptional repressor or as an alternative transcription factor that promotes TGF-β signaling. Using ordinary diffe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Andrieux, Geoffroy, Fattet, Laurent, Le Borgne, Michel, Rimokh, Ruth, Théret, Nathalie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314286/ https://www.ncbi.nlm.nih.gov/pubmed/22461896 http://dx.doi.org/10.1371/journal.pone.0033761

Ejemplares similares

An integrative modeling framework reveals plasticity of TGF-β signaling
por: Andrieux, Geoffroy, et al.
Publicado: (2014)

TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients
por: Kassem, Loay, et al.
Publicado: (2015)

The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition
por: Ruff, Michaël, et al.
Publicado: (2015)

In silico investigation of ADAM12 effect on TGF-β receptors trafficking
por: Gruel, Jérémy, et al.
Publicado: (2009)

Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

The Roles of TIF1γ in Cancer
por: Yu, Chengpeng, et al.
Publicado: (2019)

Correction: Inactivation of TIF1γ Cooperates with Kras(G12D) to Induce Cystic Tumors of the Pancreas
por: Vincent, David F., et al.
Publicado: (2009)

Simple Shared Motifs (SSM) in conserved region of promoters: a new approach to identify co-regulation patterns
por: Gruel, Jérémy, et al.
Publicado: (2011)

1. TIF1-γ associated dermatomyositis
por: Waller, Rosemary, et al.
Publicado: (2019)

Coexisting TIF1γ-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma and Anti-TIF1γ Antibody-positive Dermatomyositis
por: Nakanishi, Yu, et al.
Publicado: (2020)

Clinical characteristics of patients with anti-TIF1-γ antibodies
por: Masiak, Anna, et al.
Publicado: (2016)

Prominent dyspigmentation in a patient with dermatomyositis and TIF1-γ autoantibodies
por: Gutierrez, Daniel, et al.
Publicado: (2022)

A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma
por: Dziwis, Jennifer, et al.
Publicado: (2019)

Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
por: Megremis, Spyridon, et al.
Publicado: (2021)

Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
por: Harada, Yumi, et al.
Publicado: (2022)

E3 ubiquitin ligase TRIM21 targets TIF1γ to regulate β-catenin signaling in glioblastoma
por: Li, YanLan, et al.
Publicado: (2023)

Tracker ready for transport at TIF
por: Hoch, Michael
Publicado: (2007)

Prognostic role of Tif1γ expression and circulating tumor cells in patients with breast cancer
por: Cai, Fengfeng, et al.
Publicado: (2019)

The CMS Tracker support tube in the TIF.
por: Michael Eppard
Publicado: (2005)

Transport of the Tracker from TIF to CMS
por: Hoch, Michael
Publicado: (2007)

The evolution of TIF: transoral incisionless fundoplication
por: Ihde, Glenn M.
Publicado: (2020)

iNKT cell development is orchestrated by different branches of TGF-β signaling
por: Doisne, Jean-Marc, et al.
Publicado: (2009)

Trim33 (Tif1γ) is not required for skeletal muscle development or regeneration but suppresses cholecystokinin expression
por: Parks, Cassie A., et al.
Publicado: (2019)

Therapeutic Effects of Treating COVID-19 Vaccine-Induced Anti-TIF1-γ-Positive Dermatomyositis
por: Wu, Chih-Feng, et al.
Publicado: (2023)

NanoString technology distinguishes anti‐TIF‐1γ(+) from anti‐Mi‐2(+) dermatomyositis patients
por: Preusse, Corinna, et al.
Publicado: (2021)

Marked Improvement of Anti-TIF1-γ Antibody-Positive Dermatomyositis After Chemoradiotherapy to Relevant Nasopharyngeal Cancer
por: Tomita, Natsuo, et al.
Publicado: (2021)

Images of the CMS Tracker Integration Facility (TIF)
por: Eppard, M
Publicado: (2008)

Diseño de prototipo de rastro "TIF"
por: Altamirano Juárez, Rosa Laura
Publicado: (2009)

TIF1 Proteins in Genome Stability and Cancer
por: McAvera, Roisin M., et al.
Publicado: (2020)

MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2
por: Yin, Hong, et al.
Publicado: (2007)

Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers
por: Imai, Ryosuke, et al.
Publicado: (2021)

Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
por: Wang, Longqiang, et al.
Publicado: (2018)

The disintegrin and metalloproteinase ADAM12 contributes to TGF-β signaling through interaction with the type II receptor
por: Atfi, Azeddine, et al.
Publicado: (2007)

Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
por: Parkes, Joanna E., et al.
Publicado: (2018)

Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker”: A case report
por: Karino, Kohei, et al.
Publicado: (2018)

Anti-TIF-1γ Antibody Detection Using a Commercial Kit vs In-House Immunoblot: Usefulness in Clinical Practice
por: Mariscal, Anaís, et al.
Publicado: (2021)

Expression of the MOZ-TIF2 oncoprotein in mice represses senescence
por: Largeot, Anne, et al.
Publicado: (2016)

Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report
por: Kubeček, Ondřej, et al.
Publicado: (2016)

Machine Learning Algorithms Identify Clinical Subtypes and Cancer in Anti-TIF1γ+ Myositis: A Longitudinal Study of 87 Patients
por: Zhao, Lijuan, et al.
Publicado: (2022)

Circulating VEGF-A, TNF-α, CCL2, IL-6, and IFN-γ as biomarkers of cancer in cancer-associated anti-TIF1-γ antibody-positive dermatomyositis
por: Li, Xiaomeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_986klkcfivsa7j5bvbfi3e9clf